Moderna's new COVID-19 vaccine mNexspike approved by FDA…
May 31, 2025 · The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine …
Moderna's New Lower-Dose COVID-19 Vaccine, mNexspike, Approved by FDA
TUESDAY, June 3, 2025 -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory …
FDA approves Moderna's next-generation Covid vaccine for …
Jun 1, 2025 · The U.S. Food and Drug Administration has approved Moderna's next-generation Covid-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first …
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine …
May 31, 2025 · Participants received either a 10 μg dose of mRNA-1283 or a 50 μg dose of mRNA-1273. mRNA-1283 showed a 9.3% higher relative vaccine efficacy (rVE) compared to …
FDA Approves Moderna’s New COVID Vaccine With Restricted …
June 2, 2025 -- The FDA has approved Moderna's new COVID-19 shot, an mRNA vaccine, with some limits on who can get it. The vaccine, called mNexspike, is for people who’ve previously …
FDA grants limited approval to new Covid vaccine from Moderna …
Jun 1, 2025 · Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with …
Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA
Jun 3, 2025 · The innovative design of mNexspike allows for a much lower dose, about one-fifth of the dosage used in the current vaccine (Spikevax), a reduction achieved by refining the …
FDA approves Moderna’s lower-dose COVID-19 vaccine for …
Jun 2, 2025 · The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to 64 years at high risk for severe …
FDA approves Moderna’s new lower-dose COVID-19 vaccine
May 31, 2025 · The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a …
FDA approves Moderna's new lower-dose COVID-19 vaccine
Jun 1, 2025 · The Food and Drug Administration approved the new vaccine for use in all adults 65 and older and for people aged 12 to 64 who have at least one health condition that puts them …
- Some results have been removed